Vascular endothelial growth factor (VEGF) and hypoxia inducible factor-1 alpha (HIF-1α) in lacrimal gland Adenoid cystic carcinoma: Correlation with clinical outcome

Purpose: VEGF and HIF-1 alpha are important regulators of angiogenesis, overexpressed in various tumors. Lacrimal gland Adenoid cystic carcinoma (ACC) is a malignant tumor whose angiogenic properties remain unexplored. This study was designed to evaluate the expression of HIF-1 alpha and VEGF in lacrimal gland ACC. Methods: VEGF and HIF-1 alpha immunoexpression was undertaken in 30 lacrimal gland ACC cases. mRNA expression of VEGF and HIF-1 alpha was analysed in 17 cases by quantitative real time PCR. The results obtained were correlated with clinicopathological features and survival of the patients to determine the prognostic significance. Results: Immunoexpression of HIF-1 alpha and VEGF was seen in 36.6% and 46.6% ACC cases. HIF-1 alpha expression showed significant association with advanced T-stage (P = 0.001) and VEGF with intracranial extension (P = 0.014) and solid histological pattern (P = 0.045). HIF-1 alpha mRNA expression was seen in 29.4% cases and showed significant association with perineural invasion (P = 0.027). Recurrence occurred in 60%, distant metastasis in 20% and death in 20% cases. Survival analysis revealed that patients with HIF-1 alpha, VEGF immunoexpression, solid histological pattern, perineural invasion, bone erosion, intracranial extension, metastasis, advanced Tstage, and exenteration had poor survival. On multivariate analysis VEGF immunoexpression (hazard ratio, 16.785; 95% confidence interval, 1.872-150.495; P = 0.012) was the most significant poor prognostic factor. Conclusions: This study demonstrates that VEGF is a potential predictor for poor clinical outcome in lacrimal gland Adenoid cystic carcinoma.

Automated summary

This study revealed that the expression of HIF-1 alpha and VEGF in lacrimal gland Adenoid cystic carcinoma is associated with clinicopathological features and survival rates. VEGF may serve as a potential predictor for poor clinical outcomes in this type of carcinoma.